Article 1
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2016/2016 of 17 November 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, benzoic acid, flazasulfuron, mecoprop-P, mepanipyrim, mesosulfuron, propineb, propoxycarbazon, propyzamide, propiconazole, Pseudomonas chlororaphis Strain: MA 342, pyraclostrobin, quinoxyfen, thiacloprid, thiram, ziram, zoxamide (Text with EEA relevance )
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 54, Propineb, the date is replaced by β31 January 2018β; (2) in the sixth column, expiration of approval, of row 55, Propyzamide, the date is replaced by β31 January 2018β; (3) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by β31 January 2018β; (4) in the sixth column, expiration of approval, of row 58, Propiconazole, the date is replaced by β31 January 2018β; (5) in the sixth column, expiration of approval, of row 73, Thiram, the date is replaced by β30 April 2018β; (6) in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by β30 April 2018β; (7) in the sixth column, expiration of approval, of row 75, Mesosulfuron, the date is replaced by β31 January 2018β; (8) in the sixth column, expiration of approval, of row 76, Propoxycarbazone, the date is replaced by β31 January 2018β; (9) in the sixth column, expiration of approval, of row 77, Zoxamide, the date is replaced by β31 January 2018β; (10) in the sixth column, expiration of approval, of row 79, Benzoic acid, the date is replaced by β31 January 2018β; (11) in the sixth column, expiration of approval, of row 80, Flazasulfuron, the date is replaced by β31 January 2018β; (12) in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by β31 January 2018β; (13) in the sixth column, expiration of approval, of row 82, Quinoxyfen, the date is replaced by β30 April 2018β; (14) in the sixth column, expiration of approval, of row 89, Pseudomonas chlororaphis Strain: MA 342, the date is replaced by β30 April 2018β; (15) in the sixth column, expiration of approval, of row 90, Mepanipyrim, the date is replaced by β30 April 2018β; (16) in the sixth column, expiration of approval, of row 91, Acetamiprid, the date is replaced by β30 April 2018β; (17) in the sixth column, expiration of approval, of row 92, Thiacloprid, the date is replaced by β30 April 2018β.
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.